This page shows the latest RECOVERY trial news and features for those working in and with pharma, biotech and healthcare.
The FDA’s final decision was based on results from the University of Oxford-led RECOVERY trial, as well as the EMPACTA trial, the first global, phase 3 study in ... The FDA’s decision was based on positive results from the SAVE-MORE phase 3 trial
NHS data through digital clinical trial services and Trusted Research Environments. ... This includes the RECOVERY trial which made use of NHS data through NHS DigiTrials and led to the discovery of Dexamethasone, the world’s first proven treatment for
The RECOVERY trial is the biggest study of COVID-19 treatments in the world, involving more than 47, 000 participants in the UK. ... Since March 2020, the RECOVERY trial has tested a variety of potential therapies for patients admitted to hospital with
The COVID-19 indication is based on extensive data from four major trials, including the University of Oxford’s RECOVERY trial, the phase 3 study that looked at whether several potential
The phase 3 trial evaluated REGEN-COV (casirivimab with imdevimab) in 4, 567 high-risk outpatients with COVID-19. ... In June, the UK-based RECOVERY trial showed REGEN-COV improved survival in hospitalised COVID-19 patients who lack an immune response to
infection, including the UK RECOVERY trial.
More from news
Approximately 1 fully matching, plus 16 partially matching documents found.
No results were found
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...